Philadelphia-Area Life Sciences Companies With the Biggest Stock Hits in First Half of 2022

Midsize and startup drug developers in the Philadelphia region saw their market capitalization drop by nearly $3.7 billion during the first half of 2022.

Read the full article at: www.bizjournals.com